Therapeutic devices developer Abyrx has received 510(k) approval from the US Food and Drug Administration (FDA) for its new resorbable hemostatic bone putty called Hemasorb Plus that achieves hemostasis by mechanical tamponade. Hemasorb ...
Abyrx, a US-based therapeutic device company, has received the US Food and Drug Administration (FDA) approval for its new Absorbable Hemostatic Bone Putty (AHBP) for clinical use. AHBP is a surgical ready-to-use product which achieves ...
Tags: Abyrx, Bone Putty